Filing Details

Accession Number:
0000899243-16-021423
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-02 06:21:38
Reporting Period:
2016-06-01
Filing Date:
2016-06-02
Accepted Time:
2016-06-02 06:21:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1358762 Reata Pharmaceuticals Inc RETA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193284 William Rose 3963 Maple Avenue, Suite 200
Dallas TX 75219
Yes No No Yes
1675029 E. Charles Gale 3963 Maple Avenue, Suite 200
Dallas TX 75219
No No No Yes
1675048 Ira Rollover Fidelity Rose W. Edward 3963 Maple Avenue, Suite 200
Dallas TX 75219
No No No Yes
1675056 Iii Rose W. Edward Of Estate 3963 Maple Avenue, Suite 200
Dallas TX 75219
No No Yes Yes
1675060 Trust 2002 Rose William John 3963 Maple Avenue, Suite 200
Dallas TX 75219
No No No Yes
1675064 P. Evelyn Rose 3963 Maple Avenue, Suite 200
Dallas TX 75219
No No No Yes
1675105 Trust 2001 Rose Henry Charles 3963 Maple Avenue, Suite 200
Dallas TX 75219
No No No Yes
1675112 Ira Rollover Fidelity Gale E. Charles 3963 Maple Avenue, Suite 200
Dallas TX 75219
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2016-06-01 11,618 $0.00 11,618 No 4 C Direct
Class A Common Stock Acquisiton 2016-06-01 168,720 $0.00 168,720 No 4 C Direct
Class A Common Stock Acquisiton 2016-06-01 7,886 $0.00 7,886 No 4 C Direct
Class A Common Stock Acquisiton 2016-06-01 1,426 $0.00 1,426 No 4 C Direct
Class A Common Stock Acquisiton 2016-06-01 29 $0.00 29 No 4 C Direct
Class A Common Stock Acquisiton 2016-06-01 20 $0.00 20 No 4 C Indirect By trust
Class A Common Stock Acquisiton 2016-06-01 45 $0.00 45 No 4 C Indirect By trust
Class A Common Stock Acquisiton 2016-06-01 957,000 $11.00 957,000 No 4 P Indirect By Puffin
Class A Common Stock Acquisiton 2016-06-01 143,000 $11.00 143,000 No 4 P Indirect By Montrose
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Indirect By trust
No 4 C Indirect By trust
No 4 P Indirect By Puffin
No 4 P Indirect By Montrose
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Class B Common Stock Disposition 2016-06-01 11,618 $0.00 11,618 $0.00
Class A Common Stock Class B Common Stock Disposition 2016-06-01 168,720 $0.00 168,720 $0.00
Class A Common Stock Class B Common Stock Disposition 2016-06-01 7,886 $0.00 7,886 $0.00
Class A Common Stock Class B Common Stock Disposition 2016-06-01 1,426 $0.00 1,426 $0.00
Class A Common Stock Class B Common Stock Disposition 2016-06-01 29 $0.00 29 $0.00
Class A Common Stock Class B Common Stock Disposition 2016-06-01 20 $0.00 20 $0.00
Class A Common Stock Class B Common Stock Disposition 2016-06-01 45 $0.00 45 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
129,308 No 4 C Direct
1,877,998 No 4 C Direct
87,776 No 4 C Direct
15,869 No 4 C Direct
313 No 4 C Direct
215 No 4 C Indirect
492 No 4 C Indirect
Footnotes
  1. The Class B common stock is convertible into Class A common stock on a one-for-one basis (a) at the holder's election at any time after the date that is six months following the date of the closing of the initial public offering of the company's Class A common stock, (b) at the holder's election prior to that time subject to certain conditions, or (c) at the option of the company's board of directors, in its sole discretion, at any time or multiple times from time to time on or before the closing of the initial public offering. The conversion right of the Class B common stock has no expiration date.
  2. These shares are owned directly by William E. Rose, a director of the issuer.
  3. These shares are owned directly by the Estate of Edward W. Rose III, a ten percent owner of the issuer, for which Charles E. Gale serves as executor.
  4. These shares are owned directly by Edward W. Rose Fidelity Rollover IRA and indirectly by Evelyn P. Rose.
  5. These shares are owned directly by Charles E. Gale.
  6. These shares are owned directly by the Charles E. Gale Fidelity Rollover IRA and indirectly by Charles E. Rose.
  7. These shares are owned indirectly by William E. Rose, a director of the issuer, as co-trustee of the Charles Henry Rose 2001 Trust.
  8. These shares are owned indirectly by William E. Rose, a director of the issuer, as co-trustee of the John William Rose 2002 Trust.
  9. These shares are owned directly by Puffin Partners, L.P. ("Puffin"). Each of (a) William E. Rose, a director of the issuer, and (b) Charles E. Gale serve as co-managers of the general partner of Puffin.
  10. These shares are owned directly by Montrose Investments I, L.P. ("Montrose"), and indirectly by William E. Rose, a director of the issuer, as sole shareholder and sole manager of the general partner of Montrose.